Life Sciences Tools & Services Industry Severance Agreements

Second Amended and Restated Executive Severance Agreement, dated September 18, 2023, between the Company and Stephen Moore (Personalis, Inc., Filed With SEC on February 28, 2024)

Third Amended and Restated Executive Severance Agreement, dated September 25, 2023, between the Company and Richard Chen (Personalis, Inc., Filed With SEC on February 28, 2024)

Third Amended and Restated Executive Severance Agreement, dated September 25, 2023, between the Company and Aaron Tachibana (Personalis, Inc., Filed With SEC on February 28, 2024)

Second Amended and Restated Executive Severance Agreement, dated September 25, 2023, between the Company and Christopher Hall (Personalis, Inc., Filed With SEC on February 28, 2024)

Amended and Restated Participation Notice to the Key Employee Severance Plan, dated as of March 28, 2023, by and between SomaLogic, Inc. and Roy Smythe (CM Life Sciences II Inc., Filed With SEC on May 15, 2023)

Form of Participation Agreement for the Amended and Restated Executive Severance Policy (Lifesci Acquisition II Corp., Filed With SEC on May 15, 2023)

Science 37 Holdings, Inc. Amended and Restated Executive Severance Policy (Lifesci Acquisition II Corp., Filed With SEC on May 15, 2023)

Second Amended and Restated Executive Severance Agreement, dated March 8, 2023, between the Company and Richard Chen (Personalis, Inc., Filed With SEC on March 8, 2023)

First Amended and Restated Executive Severance Agreement, dated March 7, 2023, between the Company and Christopher Hall (Personalis, Inc., Filed With SEC on March 8, 2023)

Second Amended and Restated Executive Severance Agreement, dated March 7, 2023, between the Company and Aaron Tachibana (Personalis, Inc., Filed With SEC on March 8, 2023)

Key Employee Severance Plan, dated October 17, 2022 (CM Life Sciences II Inc., Filed With SEC on October 18, 2022)

Akoya Biosciences, Inc. Executive Severance Plan (Akoya Biosciences, Inc., Filed With SEC on March 29, 2022)

Science 37 Holdings, Inc. Executive Severance Policy (Lifesci Acquisition II Corp., Filed With SEC on March 22, 2022)

Amended and Restated Executive Severance Agreement, by and between Aaron Tachibana and the Registrant, dated February 23, 2022 (Personalis, Inc., Filed With SEC on February 24, 2022)

Amended and Restated Executive Severance Agreement, by and between Dr. Richard Chen and the Registrant, dated February 23, 2022 (Personalis, Inc., Filed With SEC on February 24, 2022)

Amended and Restated Executive Severance Agreement, by and between John West and the Registrant, dated February 23, 2022 (Personalis, Inc., Filed With SEC on February 24, 2022)

Cytek Biosciences, Inc. Amended and Restated Severance Benefit Plan (Cytek BioSciences, Inc., Filed With SEC on July 19, 2021)

Quantum-Si Incorporated Executive Severance Plan (HighCape Capital Acquisition Corp., Filed With SEC on July 6, 2021)

Executive Severance Plan (Singular Genomics Systems, Inc., Filed With SEC on May 24, 2021)

First Amendment to Severance Agreement, dated December 4, 2020, between SomaLogic, Inc. and Lawrence Gold (CM Life Sciences II Inc., Filed With SEC on May 14, 2021)

Severance Agreement, dated September 1, 2020, between SomaLogic, Inc. and Lawrence Gold (CM Life Sciences II Inc., Filed With SEC on May 14, 2021)

Executive Severance Plan (AbCellera Biologics Inc., Filed With SEC on December 7, 2020)

Form of Executive Severance Agreement between Adaptive Biotechnologies Corporation and certain of its executive officers (Adaptive Biotechnologies Corp, Filed With SEC on August 10, 2020)

Thermo Fisher Scientific Inc. Executive Severance Policy (Thermo Fisher Scientific, Filed With SEC on August 2, 2019)

Executive Severance Agreement between the Registrant and Charles Sang, dated May 1, 2019 (Adaptive Biotechnologies Corp, Filed With SEC on May 30, 2019)

Executive Severance Agreement between the Registrant and Lance Baldo, MD, dated April 22, 2019 (Adaptive Biotechnologies Corp, Filed With SEC on May 30, 2019)

Executive Severance Agreement between the Registrant and Chad Cohen, dated May 1, 2019 (Adaptive Biotechnologies Corp, Filed With SEC on May 30, 2019)

FLUIDIGM CORPORATION EMPLOYMENT AND SEVERANCE AGREEMENT (FLUIDIGM CORP, Filed With SEC on November 9, 2016)

INC RESEARCH HOLDINGS, INC. EXECUTIVE SEVERANCE PLAN (AdoptedSeptember 15, 2016) (Syneos Health, Filed With SEC on September 15, 2016)

FLUIDIGM CORPORATION AMENDED AND RESTATED EMPLOYMENT AND SEVERANCE AGREEMENT (FLUIDIGM CORP, Filed With SEC on December 11, 2012)

THERMO FISHER SCIENTIFIC INC. AMENDMENT NO. 2 TO 2009 RESTATEMENT OF EXECUTIVE SEVERANCE AGREEMENT (Thermo Fisher Scientific, Filed With SEC on February 24, 2011)

THERMO FISHER SCIENTIFIC INC. AMENDMENT NO. 2 TO EXECUTIVE SEVERANCE POLICY (Thermo Fisher Scientific, Filed With SEC on February 24, 2011)

2009 RESTATEMENT OF EXECUTIVE SEVERANCE AGREEMENT (Thermo Fisher Scientific, Filed With SEC on November 25, 2009)

CHARLES RIVER LABORATORIES Severance Agreement (Charles River Laboratories, Filed With SEC on February 23, 2009)

EX-10.2 Thermo Fisher Scientific Inc. Executive Severance Policy (Thermo Fisher Scientific, Filed With SEC on May 19, 2008)

SEVERANCE AGREEMENT (PRESSURE BIOSCIENCES INC, Filed With SEC on March 27, 2008)

AMENDMENT NO. 1 TO EXECUTIVE SEVERANCE AGREEMENT (Thermo Fisher Scientific, Filed With SEC on November 14, 2006)

Category

Industry

Companies

Contracts

Severance Agreements in the Life Sciences Tools & Services Industry